79 related articles for article (PubMed ID: 4180185)
1. [Autoimmune aspect of exophthalmic goiter. Activation of cervical lymphoid structures and production of IgM and IgG immunoglobulins].
Mahaux JE; Delcourt R; Chamla-Soumenkoff J; Nagel M
Ann Endocrinol (Paris); 1969; 30(1):139-46. PubMed ID: 4180185
[No Abstract] [Full Text] [Related]
2. [Elevation of IgM and IgG immunoglobulins and ophthalmopathic reaction after intake of triiodothyronine in a thyroidectomized Graves' disease patient. Reversible rupture of the autoimmune equilibrium and the Arthus phenomenon].
Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Levin S
Ann Endocrinol (Paris); 1972; 33(1):86-91. PubMed ID: 4266493
[No Abstract] [Full Text] [Related]
3. Concentration of TSH-receptor antibodies (TBII) in the sera of patients with immunogenic hyperthyroidism (Graves' disease) receiving antithyroid medication.
Budihna N; Pavlin K; Porenta M
Radiobiol Radiother (Berl); 1987; 28(1):101-6. PubMed ID: 2438715
[No Abstract] [Full Text] [Related]
4. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F
Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007
[TBL] [Abstract][Full Text] [Related]
5. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
Bech K
Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
[No Abstract] [Full Text] [Related]
6. The effect of triiodothyronine on cervical lymphoid structures, thyroid activity, IgG and IgM immunoglobulin level and exophthalmos in Graves' disease.
Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Nagel N; Levin S
Acta Endocrinol (Copenh); 1969 Jul; 61(3):400-6. PubMed ID: 4184992
[No Abstract] [Full Text] [Related]
7. [Levamisole and thyroid diseases].
Epishin AV
Klin Med (Mosk); 1983 Nov; 61(11):21-4. PubMed ID: 6198555
[No Abstract] [Full Text] [Related]
8. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
[TBL] [Abstract][Full Text] [Related]
9. Immune responses in stroma and basement membranes of the Graves' disease thyroid(IgM; IgE, IgG, and complement).
Werner SC; Wegelius O; Hsu KC
Trans Assoc Am Physicians; 1971; 84():139-43. PubMed ID: 4950610
[No Abstract] [Full Text] [Related]
10. Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
Kim WB; Cho BY; Park HY; Lee HK; Kohn LD; Tahara K; Koh CS
J Clin Endocrinol Metab; 1996 May; 81(5):1758-67. PubMed ID: 8626830
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoglobulin levels in thyroid disease.
Glynne A; Thomson JA
Clin Exp Immunol; 1972 Sep; 12(1):71-8. PubMed ID: 4628405
[TBL] [Abstract][Full Text] [Related]
12. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
[TBL] [Abstract][Full Text] [Related]
13. Thyroid stimulating immunoglobulin in Graves' disease.
Luttrell BM; Hales IB
Aust N Z J Med; 1981 Jun; 11(3):293-8. PubMed ID: 6170289
[TBL] [Abstract][Full Text] [Related]
14. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
[No Abstract] [Full Text] [Related]
15. [Correlation between serum antithyroid antibody titer and changes in thyroid function during therapy of Graves' disease with antithyroid drugs].
Gao Y; Kong WL; Gao YM
Zhonghua Nei Ke Za Zhi; 1987 Feb; 26(2):86-9, 125. PubMed ID: 2440645
[No Abstract] [Full Text] [Related]
16. [Levels of immunoglobulins A, G and M, and beta-1-C/beta-1-A globulin in the serum of patients with autoimmune thyroid gland diseases (author's transl)].
Engelberth O; Límanová Z; Malíková J
Sb Lek; 1977 Aug; 79(7-8):206-9. PubMed ID: 71755
[No Abstract] [Full Text] [Related]
17. [Current approaches to the treatment of diffuse toxic goiter].
Balabolkin MI
Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
[No Abstract] [Full Text] [Related]
18. Immune regulatory plasmacytoid dendritic cells selectively accumulate in perithyroidal lymph nodes of patients with Graves disease: implications for the understanding of autoimmunity.
Hassan I; Brendel C; Zielke A; Burchert A; Danila R
Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):46-51. PubMed ID: 24505891
[TBL] [Abstract][Full Text] [Related]
19. [Anomalies of cellular immunity in Graves' disease treated by synthetic antithyroid drugs: effects on prognosis].
Allannic H; Genetet N; Edan G; Merdrignac G; Simon M; Genetet B
Pathol Biol (Paris); 1987 Dec; 35(10):1333-8. PubMed ID: 2449649
[TBL] [Abstract][Full Text] [Related]
20. Levels of immunoglobulins IgG, IgA, IgM and lysozyme in 10-year-old children from different regions and the condition of the lymphatic apparatus. II. Condition of cervical lymph nodes in connection with some immunological indices and with different environment.
Wagnerová M; Wagner V; Kriz J; Munzarová J; Foltýnová J; Wokounová D
J Hyg Epidemiol Microbiol Immunol; 1977; 21(3):324-34. PubMed ID: 564369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
